Effects of organometals on cellular signaling. II. Inhibition of reincorporation of free arachidonic acid and influence on paf-acether synthesis by triethyllead. by Krug, H F et al.
Effects of Organometals on Cellular Signaling.
II. Inhibition of Reincorporation of Free
Arachidonic Acid and Influence on paf-acether
Synthesis by Triethyllead
Harald F. Krug,' Dorit Mattern," Jocelyne Bidault,2 and Ewa Ninio2
1Kernforschungszentrum Karlsruhe, Institute of Genetics and Toxicology, Karlsruhe, Germany; 2INSERM U
200, Universite Paris-Sud, Clamart, France
Organometal compounds affect many enzymes, especially those containing SH-groups as acyl- and acetyltransferases involved in lysophospholipid
reacylation. In HL-60 cells, organotin and -lead compounds stimulate phospholipase A2 activity, contributing thus to increase the level of lysophos-
pholipids. In the present study, we have tested whether paf-acether (paf) biosynthesis was affected by treatment with triethyllead (Et3PbCI) in HL-60
cells. Et3PbCI inhibits the incorporation of exogenous arachidonic acid in the presence of high (1 50 pM) but not low concentrations (< 1 pM). High
concentrations of the lead compound are unable to induce paf formation by itself, however, lower concentrations (< 10 pM) acted synergistically
with TPA or fMLP to stimulate paf formation. Whereas unstimulated cells produced 0.4 pmole paf/2 x 106 cells, the stimulation with low fMLP
(0.1 pM) resulted in the synthesis of 1.7 pmole and with low TPA (2 ng/ml) in 0.5 pmole paf. Preincubation of the cells with 10 pM Et3PbCI for 20 to
30 min increased the amount of paf formed by these cells to 3.3 pmole after treatment with 0.1 pM fMLP and 1.5 pmole after TPA. Furthermore,
the results showed an inhibition of acetyltransferase (the key enzyme of paf synthesis) by the high and not by low concentrations of the lead com-
pound. We conclude that low concentrations of Et3PbCI (< 10 pM) may act as a synergistic inducer of paf synthesis initiated via a receptor-coupled
stimulation. - Environ Health Perspect 102(Suppl 3):331-334 (1994).
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Introduction
The balance of deacylation and reacyla-
tion of cellular membrane phospholipids
plays an important role in many cell
types as well as in multiple physiological
and pathological processes. More and
more investigations have shown that
environmental toxicants as heavy metal
compounds affect this sensitive mecha-
nism within human blood platelets
(1-4), macrophages (5), granulocytes
(6-8), as well as in fibroblasts (9). These
xenobiotics enhance the deacylation
either via the activation ofphospholipase
A2 (2,7,8) or the inhibition of fatty
acid-CoA synthetase or lysophospholipid
acyltransferase (4-6) and all lead to an
increased amount of free fatty acids, pre-
dominantly of arachidonic acid. This
precursor of the biologically active
eicosanoids acts in concert with other
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lipid mediators. Another important path-
way coupled to this deacylation-reacyla-
tion cycle is involved in paf production,
a very potent mediator of anaphylaxis
and inflammation (10): The acetylation
of lyso paf-acether (lyso paf, 1-O-alkyl-
2-lyso-sn-glycero-3-phosphocholine) by
the activity of the key enzyme
lyso paf:acetyl-CoA acetyltransferase
mediates the biosynthesis ofpaf(11-13).
As mentioned above, the release of
arachidonic acid from phospholipids is
stimulated by organometals and its reacy-
lation into lysophospholipids by acyl-
transferases is inhibited. It is well
documented that these effects induce an
increase of arachidonic acid as well as of
its metabolites, the eicosanoids, but little
is known about the destiny of the
increased amount of lysophospholipids.
To assess the possible role of these
lysophospholipids in the biosynthesis of
paf we examined the activity of acetyl-
transferase and the amount of paf pro-
duced after treatment with triethyllead
(Et3PbCl). Our results suggest that low
concentrations of the organolead com-
pound may act synergistically together
with other cell agonists in the augmenta-
tion ofpafsynthesis in HL-60 cells.
Materials and Methods
Chemicals
RPMI medium, fetal calf serum and other
medium additives were obtained from
Gibco (Eggenstein, Germany). The cal-
cium ionophore A 23187, 12-O-tetrade-
canoylphorbol 13-acetate (TPA), lyso paf,
acetyl-CoA, and fMet-Leu-Phe (fMLP)
were from Sigma (Munich, Germany). The
[1-14C]arachidonic acid (2.07 GBq/
mmole) and the [N-methyl-14C]platelet
activating factor (2.04 GBq/mmole) were
purchased from Amersham (Braunschweig,
Germany) and the [acetyl-3H]coenzyme A
(115.07 GBq/mmol) was from New
England Nuclear (Dreieich, Germany).
Triethyllead chloride was obtained from
Ventron Alpha Products (Karlsruhe,
Germany) and was further purified prior to
use. All other chemicals were of analytical
grade.
Incubation ofHL-60 Cells
HL-60 cells were grown in suspension cul-
ture in RPMI 1640 medium supplemented
with 15% heat-inactivated fetal calf serum,
1.5% glutamate (200 mM in H20),
1% nonessential amino acid solution,
1% sodiumpyruvate (100 mM in H20),
and 0.5% of a mixture of streptomycin
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Figure 1. Inhibition of arachidonic acid incorporation into lipids of HL-60 cells after preincubation with Et3PbCI.
Suspensions of differentiated HL-60 cells were vehicle-treated (control, A) or preincubated with Et3PbCI (B, C) for 1 hr
before radioactive-labeled arachidonic acid was added to the incubation mixtures. After further incubation for 1 hr the
lipids were extracted and separated by thin layer chromatography. Shown is the incorporation of arachidonic acid into
thevarious lipid classes and calculated as percentage oftotal label. Values arethe mean ofthree experiments. No signif-
icant difference between 0.5 pM Et3PbCI-treated (B) and control cells (A) could be detected, whereas the values of PC,
PE, NL, and free arachidonic acid of the 50 pM-treated cells (C) differ from the control (p < 0.005; unpaired t-test).
PC, phosphatidylcholine; PI, phosphatidylinositol; PS, phosphatidylserine; PE, phosphatidylethanolamine; NL, neutral
lipids; fM, freearachidonic acid.
(1 mg/ml) and penicillin (1000 IU/ml).
The cells were induced to differentiate to
mature granulocytes by the addition of
1.3% dimethyl sulfoxide for 5 days. They
were harvested by centrifugation, washed
once with RPMI without any additives and
finally resuspended in medium containing
1% dimethyl sulfoxide and 3.3% fetal calf
serum at a concentration of 1 x
107 cells/ml. Experiments were started after
a rest period of30 min.
PafAssay
Experiments were carried out with cell sus-
pensions (2 x 106 cells/ml). After treatment
ofthe cells with calcium ionophore (10 pM
or 1 pM), fMLP (1 pM or 0.1 pM), TPA
(10 ng/ml or 2 ng/ml), or Et3PbCl
(100 pM or 10 pM), the reaction was
stopped by adding 4 ml ethanol. After 1 hr
ofstirring at room temperature the samples
were centrifuged at 3,000g for 5 min. The
ethanolic supernatants were dried and
stored at -20°C until assay. Pafactivity was
measured by aggregation of aspirin-treated
(0.1 mM) washed rabbit platelets in the
presence of creatine phosphate (0.7 mM)
and creatine phosphokinase (13.9 U/ml).
Results are expressed in pmole paf per
2 x 106 cells, calculated over a calibration
curve established with synthetic pafC 18:0
(12). All aggregations were due to pafsince
the specific paf antagonist BN 52021
inhibited all samples.
AssayforAcetyltansferase
The acetyltransferase activity in control
cells or in cells treated for 15 min at 37°C
with calcium ionophore A 23187 (1 pM)
in the presence or absence of various con-
centrations of Et3PbCl was measured as
described previously (11). Briefly, the cells
(5 x 106 cells in 500 pl) were centrifuged
and resuspended in 500 pl of 0.9% NaCl
and sonicated (three pulses of5 sec) on ice.
The cell lysate (100 pl) was added to the
reaction mixture (0.4 ml, pH 7.0), which
contained 4.2 mM HEPES, 137 mM
NaCl, 2.6 mM KCI, 1.25 mg bovine
serum albumin, and the following sub-
strates: 200 pM acetyl-CoA, 11 kBq
[3H]acetyl-CoA, and 20 pM 2-lyso paf.
The reaction was carried out for 12 min at
37°C and was then stopped by adding
400 pl 5% acetic acid and a mixture of
chloroform/methanol (1:1, v/v) containing
11,000 dpm of ['4C]paf as an internal stan-
dard. Extraction was performed as
described previously (13); the amount of
[3H]pafformed in the assay is expressed in
% of maximal stimulation after calcium
ionophore treatment.
Lipid Extraction andSeparation of
LipidClasses
After incubation of the cell suspensions
with [1-_4C]arachidonic acid for 1 hr, the
lipids were extracted as reported earlier (7).
The extract was dried under nitrogen, dis-
solved in chloroform, spotted onto SIL G
polyester plates (20 cm x 20 cm) and sepa-
rated by thin-layer chromatography by use
of a sequential double system (7). This sys-
tem gives good separation of phospho-
lipids, free fatty acids and neutral lipids.
The Rf values for the lipid classes were
determined by comparison of their migra-
tion with that of commercial standards.
Radioactive lipids were localized by using
autoradiography, cut out, and counted for
radioactivity in a liquid scintillation
counter.
Results
Organolead-inhibited Incorporation of
ExogenousArachidonicAcid
The incubation ofHL-60 cells with exoge-
nous ["4C]arachidonic acid resulted in 65%
uptake of the fatty acid within the first
60 min, 50% ofthe total radioactivity was
incorporated into the phospholipids (the
bulk was found in PC) and 16% into the
neutral lipids (Figure IA).
As compared with vehicle-treated con-
trol cells, Et3PbCl inhibited the incorpora-
tion of exogenous arachidonic acid into
various lipid classes only when added in
high concentrations (Figure IC). One hun-
dred times lower concentrations reduced
the incorporation into the different lipid
classes to only a minor not significant
extent (Figure 1B). Preincubations with the
same low concentration for 24 hr before
exogenous arachidonic acid was added
showed no detectable effect (data not
shown). It is apparent from Figure 1C that
the label is reduced by high amounts of
Et3PbCl mainly within phosphatidyl-
choline, phosphatidylethanolamine, and
the neutral lipids by 83, 80, and 94%,
respectively. Other lipids such as phos-
phatidylinositol or phosphatidylserine are
unaffected during the incubation time.
Effecs ofEt3PbCI onStimulated
ActivityofAcetyltransferase
Since various heavy metal compounds
inhibit the acyltransferase, we were inter-
ested in the effect of organolead on the
activity ofacetyltransferase because it is the
key enzyme for paf production from its
lyso paf precursors. The acetyltransferase
activity could be stimulated 4-fold by
preincubation of HL-60 cells with calcium
ionophore. Concentrations up to 10 pM
did not inhibit notably acetyltransferase
whereas 40 pM of Et3PbCI reduced the
enzyme activity down to basal level (Figure
2). Moreover, slightly higher concentra-
tions (50 pM) blocked the enzyme below
basal activity.
E2PbCl andpafFormation in
Differentiated HL-60 Cells
Differentiated HL-60 cells could be stimu-
lated with various compounds to produce
paf. The calcium ionophore A 23187
induced the formation oflarge amounts of
this lipid mediator. Smaller but significant
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Figure 2. Inhibition of calcium ionophore stimulated
acetyltransferase activity by Et3PbCI. Cells were preincu-
bated with or without Et3PbCI (as indicated on the
abscissa) for 15 min and then stimulated for further
15 min bythe addition of 1 pM A23187. Cellswere subse-
quently lysed and the acetyltransferase activity was mea-
sured by incubating for 12 min the cell lysate in the
presence of 20 pM lyso paf and 200 pM [3Hlacetyl-CoA.
The dashed line indicates the activity of the enzyme in
unstimulated control cells ± SEM. Results are expressed
in percent related to ionophore stimulation (100%) as indi-
cated onthe ordinate. Values arethe mean ofthree exper-
iments with different enzyme preparations carried out in
duplicate ±SEM.
amounts of paf were formed when cells
were stimulated with fMLP as well as TPA
(Figure 3). The paf formation was nearly
unaffected in cells treated either with
10 pM or 100 pM Et PbCl (Figure 3).
In the next setofWexperiments we incu-
bated the HL-60 cells with the low
amounts of the three substances, 0.1 pM
fMLP, 2 ng/ml TPA, or 10 pM Et3PbCl.
As shown in Figure 4 (open bars) only
fMLP (1.7 pmole/2 x 106 cells) induced a
significant production ofpaf.
Although Et3PbCl alone was not able to
stimulate pafformation it exhibited a syner-
gistic action together with fMLP or TPA.
Furthermore, it is apparent that together
with fMLP a stimulation could be detected
only when Et3PbCl was added at first
whereas the synergism with TPA was
sequence-independent (Figure 4). More
than the additive effect in paf stimulation
by the synergistic action of Et3PbCl and
fMLP was observed. Moreover, Et3PbCl
enhanced the pafproduction synergistically
together with low TPA to 145% of the
stimulatory effect ofhigh TPA alone (com-
pare Figure 3).
Discussion
Human neutrophils and other cell types
respond to exogenous stimuli, e.g., TPA,
A 23187, or fMLP, with a rapid increase of
free arachidonic acid. This is an important
metabolic pathway because the enzyme that
is involved, the phospholipase A2 (PLA2),
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Figure 3. Induction of paf formation in differentiated
HL-60 cells. Cells were incubated with the addition as
indicated on the abscissa for 15 min (fMLP), 60 min (TPA),
and 30 min (Et3PbCI). Incubations were stopped by addi-
tion of four volumes of ethanol and the organic super-
natants were brought to dryness after centrifugation. Paf
was estimated by the platelet aggregation bioassay. The
dashed line indicates the paf formation in unstimulated
control cells. Ordinate: amount of paf in pmole/2 x 106
cells. The insert shows the high values for paf biosynthe-
sis when HL-60 cells were stimulated with calcium
ionophoreA23187for 15min. Values arethe mean offour
experiments ±SEM.
also hydrolyses 1-0-alkyl-2-arachidonoyl-
sn-glycero-3-phosphocholine (14) to yield
lyso paf (15). The lyso paf formed may be
acetylated via acetyltransferase to form paf
or reacylated with fatty acid residues (16).
Therefore, the balance between these two
transferase activities plays an important role
in pafformation.
The incorporation of fatty acids into
lysophospholipids could be prevented by
the inhibition of reacylation via the acyl-
CoA-synthetase and the lysophospholipid
acyltransferase. It has been shown that not
only organomercury compounds such as
ethylmercurithiosalicylate (3,5,6), MeHgCl
(4), and p-hydroxymercurisalicylat (9)
affect these enzymes, but also organolead
inhibits the reincorporation of exogenous
arachidonic acid (7) (Figure 1). This may
lead to the assumption that the stimulated
activity of the PLA2 rises the amount of
lyso pafas well as ofarachidonic acid when
cells were treated with the organometal
compounds. We tested therefore the effect
of Et3PbCl, a severely toxic organometal
compound (8), on the activity of acetyl-
transferase. This enzyme is located at the
same cellular site as the acyltransferase
within the HL-60 cells (13). After stimula-
tion of differentiated HL-60 cells with
A 23187, the enzyme activity increased 3-
to 4-fold (17) or, as shown here, 4- to
5-fold (Figure 2) over thevalues observed in
the resting state. As demonstrated for the
reacylation pathway (18) the acetylation of
lyso paf is inhibited within the same con-
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Figure 4. Synergistic action of Et3PbCI with fMLP orTPA
in the induction of paf formation. Differentiated HL-60
cells were incubated with the additions as indicated on
the abscissa (from left to right): Et3PbCI, 30 min; TPA,
60 min; fMLP, 15 min; TPA + Et3PbCI, 10 + 50 min;
fMLP + Et3PbCI, 5+ 30 min; Et3PbCI + TPA, 30 + 30 min;
Et3PbCI +fMLP, 20+20 min; Forall incubations the same
concentrations were used: 10 pM Et3PbCI, 0.1 pM fMLP,
and 2 ng/ml TPA. Values are the mean of three to five
experiments ± SEM.
centration-range (Figure 2). In this connec-
tion it is now clear that high concentrations
(50-100 1iM) ofEt3PbCl that induce a sub-
stantial loss ofarachidonic acid from phos-
pholipids and prevents the reacylation of
the lysophospholipids not lead to an
increased paf synthesis as expected
(Figure 3). This is the consequence of the
concomitant inhibition of acetyltransferase
by high lead concentrations, whereas low
concentrations ofEt3PbCl had no effect.
On the other hand, these low concen-
trations (<10 pM) have still an effect on the
lipid metabolism in these cells (7).
Consequently, the next question points to
the different concentration-dependent
effects: does stimulation of PLA2-activity
and no inhibition of both transferases at
low Et3PbCl lead to a higher sensitivity of
the deacylation-reacylation cycle to other
stimuli? We tested the synergistic action of
organolead together with phorbolester and
the chemotactic peptide. In this case, the
assumption was verified, the paf synthesis
could be increased when HL-60 cells were
preincubated with the lead compound.
Moreover, the effect of the two stimuli
added sequentially is more than additive in
the case offMLP, when the lead compound
was the first admixture, as well as in the case
ofTPA, independent from the sequence of
stimulation. A comparable effect ofanother
organometal compound, thimerosal, was
described by Haurand and Flohe (19).
They find that this organomercury com-
pound enhances the leukotriene formation
in human leukocytes, but this stimulation is
strictly dependent on a second triggering
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signal. Moreover, the threshold concentra-
tion of the second stimuli, e.g., fMLP, is
substantially lowered after priming of the
leukocytes with thimerosal as is the case in
the experiments shown here for Et3PbCl
together with fMLP or TPA. Since these
authors found a similar concentration
dependency concerning the inhibition of
reacylation within the human leukocytes as
we did for the differentiated HL-60 cells,
they suggested a subordinate importance of
this inhibitory activity compared with the
induction of deacylation. The acetyltrans-
ferase in cultured mast cells, on the other
hand, could be triggered by incubation with
phorbol ester without accompanying paf
formation (20). To trigger the full cellular
response, additionally receptor-operated
antigen challenge was necessary.
In HL-60 cells and many other cell
types, especially those of the hematopoetic
system, the deacylation-reacylation cycle
plays an important role in the regulation of
free arachidonic acid concentration as well
as of paf formation. The eicosanoids,
metabolites ofthe arachidonic acid, and paf
are second messenger molecules with a mul-
titude offunctions, intra- as well as intercel-
lular. Particularly neutrophilic granulocytes
are able to interact with various cell types,
such as macrophages, mast cells, platelets,
polymorphonuclear leukocytes, and many
others, e.g., via their products of the phos-
pholipase A2 cascade (21) and the subse-
quently formed paf(10,22).
The results presented here demonstrate
that low concentrations of the organolead
compound, Et3PbCl, sensitize differentiated
HL-60 cells against subsequent stimulation
by other agents. These low doses do not
inhibit the acyltransferase as well as the
acetyltransferase but enhance the activity of
the PLA2, thereby increasing the rate of
deacylation-reacylation within the remodel-
ing cycle. As a result of such an enhanced
activity within this cycle is the increased paf
formation after additional stimulation. In
the case ofhigher amounts ofEt3PbCl only
arachidonic acid and its metabolites could
be detected because the inhibition ofacetyl-
transferase prevents the paf synthesis. It
seems that this mechanism is not only rele-
vant in vitro but also in vivowithin occupa-
tionally lead-exposed workers (23). In this
study it is well documented that in leuko-
cytes of lead-exposed workers the amount
ofarachidonic acid is significantly increased
and the production of LTB4 after stimula-
tion with fMLP is significantly higher than
in the control group. We described earlier
comparable effects on the arachidonic acid
metabolism for other organometals as well
(8,18) and the assumption could be made
that these compounds may lead in vivo to
increase in the level of lipid mediators,
eicosanoids and paf, which are considered
as potent mediators of inflammatory, aller-
gic, and pseudoallergic reactions (21,23).
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